Poland - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Poland Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry jumped by 12.3% year on year. With $268,990,772.83 Million PPP in 2019, the country was ranked number 22 among other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry. Poland is overtaken by Israel, which was ranked number 21 with $287,878,980.84 Million PPP and is followed by Turkey at $231,137,855.44 Million PPP. United States topped the ranking with $70,565,318,932.39 Million PPP in 2019, that is a growth of 3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania recorded the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 268,990,772.83 |
| 2018 | 256,307,429.76 |
| 2017 | 263,618,971.80 |
| 2016 | 179,859,604.05 |
| 2015 | 215,964,374.44 |
How does Poland rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 21 |
#21
Israel
|
287,878,980.84 | 2019 | -0.9 % | +0.6 % | View data | |
| 22 |
#22
Poland
|
268,990,772.83 | 2019 | +5.0 % | +12.3 % | View data | |
| 23 |
#23
Turkey
|
231,137,855.44 | 2019 | +3.0 % | +3.1 % | View data | |